ArticleOrthopaedic journal of sports medicine2026
Patient and Chondral Defect-Specific Characteristics an Associated Matrix-Induced Autologous Chondrocyte Implantation Conversion Rates Following Biopsy.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Focal chondral defects in the knee lead to swelling, discomfort, and mechanical symptoms, resulting in disability and loss of function. Matrix-induced autologous chondrocyte implantation (MACI) has emerged as a viable treatment option, with satisfactory clinical outcomes reported compared with microfracture. Patient and lesion-specific variables associated with MACI after biopsy remain largely underreported. Purpose: To examine patient- and defect-specific characteristics associated with conversion to MACI after biopsy from a single institution. Study Design: Cohort study; Level of evidence, 3. Methods: A retrospective chart review of prospectively collected data from June 2018 to March 2025 was performed. Inclusion criteria included patients ≥15 years of age with an arthroscopically confirmed focal International Cartilage Regeneration & Joint Preservation Society (ICRS) grade 2 to 4 knee chondral lesion undergoing chondral biopsy (phase 1). Patient and chondral defect characteristics were assessed using univariate and multivariate regression analyses to determine factors associated with conversion to MACI (phase 2). Results: A total of 104 patients (mean patient age, 31.4 ± 11.4 years) undergoing chondral biopsy were identified. MACI was performed in 28.8% (30/104) of patients at a mean of 9.8 ± 10.2 months from biopsy. Patients with a history of previous knee surgery ( Conclusion: MACI was performed in 28.8% of patients undergoing biopsy for symptomatic chondral lesions. Patients with patellar defects exhibited a significantly higher likelihood of MACI, with increased conversion rates associated with previous ipsilateral knee surgery and/or more advanced chondral defects. Patients undergoing concomitant procedures at biopsy were significantly less likely to require MACI, with lower conversion rates associated with a history of preoperative mechanical symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.